TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT00637780

Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“Study terminated on 13 April 2016 for business reasons. No safety and/or efficacy concerns contributed to the termination of the study”

The sponsor’s own words in the registry.

Life of this trial

20082009201020112012201320142015201620172018Registered2008-03-11Started2010-06Stopped2014-01Results posted2017-02-23

Vital statistics

Status
Terminated
Phase
Phase 4
Sponsor
Pfizer
Sponsor type
Industry
Conditions
Arthritis, Juvenile Rheumatoid
Interventions
Sulfasalazine
Participants
2
Sites
2
Countries
Mexico, United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.